Economic Indicators - The U.S. consumer price index rose by 0.2 percent in January, lower than the expected 0.3 percent increase, following a 0.3 percent rise in December [2][20] - The annual growth rate of consumer prices slowed to 2.4 percent in January from 2.7 percent in December, below the anticipated 2.5 percent [2][20] - Core consumer prices, excluding food and energy, increased by 0.3 percent in January, matching expectations, while the annual growth rate dipped to 2.5 percent from 2.6 percent [3][21] Stock Market Reactions - Major U.S. stock indices experienced a sell-off, with the Nasdaq dropping 469.32 points (2.0 percent), the S&P 500 falling 108.71 points (1.6 percent), and the Dow declining 669.42 points (1.3 percent) [5] - The sell-off was partly driven by concerns regarding the impact of artificial intelligence on various industries, including financial, transportation, logistics, and commercial real estate [6][8] - Cisco Systems saw a significant drop of 12.3 percent after reporting better-than-expected fiscal second-quarter results but providing disappointing guidance for the current quarter [6] Sector Performance - The NYSE Arca Networking Index fell by 3.0 percent, influenced by Cisco's performance [7] - Gold stocks experienced substantial weakness, with the NYSE Arca Gold Bugs Index declining by 6.9 percent due to a drop in gold prices [7] - Transportation stocks also faced significant declines, with the Dow Jones Transportation Index plunging by 4.0 percent amid AI concerns [7] International Market Impact - Asian stocks followed Wall Street lower, with concerns over AI's impact on various sectors influencing investor sentiment [12] - European stocks showed mixed results, with the French CAC 40 Index down by 0.3 percent, while the U.K.'s FTSE 100 Index and the German DAX Index rose by 0.1 percent and 0.3 percent, respectively [18]

Core Insights - L'Oréal remains the top player in the global beauty market, with stable rankings among major beauty groups, while only Estée Lauder and Procter & Gamble have seen changes in their positions [1] Financial Performance - In 2025, L'Oréal reported total sales of €44.05 billion (approximately ¥360.88 billion), reflecting a year-on-year growth of 4% and a consolidated growth of 1.3% [4] - Operating profit reached €8.89 billion (approximately ¥728.97 billion), marking a 2.4% increase from the previous year [4] - The North Asia region, which includes China, generated €10.08 billion (approximately ¥825.96 billion) in revenue, showing a 0.5% year-on-year growth despite a consolidated decline of 2.2% [4][14] Regional Performance - North Asia experienced a revenue decline, with the overall market environment remaining challenging, particularly in travel retail [14] - Europe remains L'Oréal's largest market, with sales of €14.86 billion (approximately ¥121.80 billion) and a consolidated growth of 4.6% [18] - North America and Latin America both saw a consolidated decline of 0.7%, with North America generating €11.72 billion (approximately ¥960.18 billion) in sales [20] - The SAPMENA-SSA market recorded the highest growth rate at 10.9%, with sales of €4.11 billion (approximately ¥337.02 billion) [23] Departmental Performance - The Professional Products division achieved sales of €5.16 billion (approximately ¥423.02 billion), with a growth rate of 5.7% [29] - The Consumer Products division reported sales of €16.09 billion (approximately ¥1318.31 billion), with a slight growth of 0.7% [31] - The Dermatological Beauty division's sales reached €7.20 billion (approximately ¥590.25 billion), with significant contributions from brands like La Roche-Posay [34] - The Luxury division, while experiencing the slowest growth, still maintained a strong operating profit of €3.49 billion (approximately ¥285.78 billion) [27] Market Trends - L'Oréal's growth has slowed, with a 1.3% increase in 2025 being the lowest in five years, indicating a shift to single-digit growth [5][7] - The company has noted a recovery in its two largest markets, the U.S. and China, with ongoing expansion in emerging markets [6] - The high-end cosmetics sector has seen continuous growth challenges, while the professional hair care segment led with a 5.7% growth [5][27] Strategic Focus - L'Oréal emphasizes the importance of the Chinese market in its global strategy, indicating a recovery phase with a return to growth [44] - The company faces challenges from local brands and changing consumer preferences, necessitating a focus on innovation and market adaptation [46][47]

Good morning. It's Friday the 13th, which sounds ominous. This is what is on today's agenda.The scare that trade hits logistics, affordability in focus again in the United States. And the Munich Security Council puts nuclear deterrent. Center stage Asian markets, it seems not immune, at least for now.To that, I fear that China currently across the benchmark, down 1.3%, snapping six days of gains. European futures pointing to very modest gains of a 10th of a percent after ending lower by about $0.05% yesterd ...

Economic Indicators - The number of Americans filing for initial jobless claims fell by 5,000 to 227,000, compared to the expected 222,000 [2] - U.S. existing home sales decreased by 8.4% month-over-month to a 16-month low of 3.91 million, weaker than the expected 4.16 million [2] - The Consumer Price Index (CPI) rose 2.4% annually, a notable drop from the previous month, with a monthly increase of 0.2% [5] Stock Market Performance - Wall Street's major indices ended in the red, with significant declines in the Magnificent Seven stocks, including Apple (AAPL) down 5% and Tesla (TSLA) down over 2% [4] - Cisco Systems (CSCO) plunged over 12% after reporting weaker-than-expected FQ2 adjusted gross margin and issuing tepid FQ3 guidance [4] - Equinix (EQIX) surged over 10% after issuing strong FY26 guidance, marking it as the top percentage gainer on the S&P 500 [4] Corporate Earnings - Notable companies such as Moderna (MRNA) and Advance Auto Parts (AAP) are set to release their quarterly results [6] - Pinterest (PINS) plunged over 19% in pre-market trading after reporting weaker-than-expected Q4 revenue and issuing below-consensus Q1 revenue guidance [13] - Applied Materials (AMAT) surged over 11% in pre-market trading after posting stronger-than-expected FQ1 results and issuing strong FQ2 guidance [13] International Market Developments - The Euro Stoxx 50 Index is down 0.09% as investors digest fresh corporate earnings reports and await key U.S. inflation data [7] - Eurozone's GDP growth for the fourth quarter stood at 0.3%, in line with preliminary estimates [8] - Spain's annual inflation rate eased more than expected in January, with CPI falling 0.4% month-over-month and rising 2.3% year-over-year [8] Pre-Market Movements - U.S. steel stocks slid in pre-market trading after reports of President Trump's plans to roll back some tariffs on steel and aluminum products, with Steel Dynamics (STLD) down over 4% [12] - Most chip stocks are moving lower in pre-market trading, with Micron Technology (MU) and Intel (INTC) falling more than 1% [12]

Company Impact - A fire at Valero's Ardmore oil refinery in Oklahoma resulted in one death from injuries sustained during the incident [1] - Valero Energy Corp has not yet provided a comment regarding the situation [1] Industry Context - The incident highlights ongoing safety concerns within the oil refining industry, which may impact operational protocols and regulatory scrutiny [1]

Group 1 - The core viewpoint of the article indicates that L'Oréal's fourth-quarter sales fell short of expectations, leading to a projected decline in its stock price by 5% to 7% [1]

Core Viewpoint - Momentum investing focuses on following a stock's recent price trends, aiming to buy high and sell higher, with the expectation that established trends will continue [1] Company Overview: L'Oreal SA (LRLCY) - L'Oreal SA currently holds a Momentum Style Score of B, indicating potential as a solid momentum pick [3][12] - The company has a Zacks Rank of 2 (Buy), which is associated with strong market outperformance [4] Price Performance - Over the past week, L'Oreal shares increased by 1.9%, while the Zacks Consumer Products - Staples industry rose by 3.92% [6] - In a longer timeframe, L'Oreal's monthly price change is 2.49%, outperforming the industry's 0.06% [6] - Over the last quarter, L'Oreal shares have risen by 15.68%, and over the past year, they are up 33.91%, compared to the S&P 500's increases of 1.65% and 15.6%, respectively [7] Trading Volume - The average 20-day trading volume for L'Oreal is 217,340 shares, which serves as a price-to-volume baseline for assessing stock performance [8] Earnings Outlook - In the past two months, three earnings estimates for L'Oreal have been revised upwards, with no downward revisions, leading to an increase in the consensus estimate from $3.15 to $3.41 [10] - For the next fiscal year, three estimates have also moved upwards without any downward revisions [10]

Group 1 - The company achieved total sales of $52.29 billion last year, reflecting a 1.3% increase on a like-for-like basis compared to the previous year [1]

It's 5AM in New York City. Good morning. I'm Vonnie Quinn with your Bloomberg Brief.Let's get you set up for the day. Traders paring back rate cutbacks following that payrolls report. Jobless claims up next.Stocks recovering from another scare trade while anthropic inching closer to a deal that would value the farm at $350 billion. And midterm anxieties rise for President Trump as the House passes a bill targeting his levies on Canadian imports. So futures are pointed higher today.Now, yesterday, we had ano ...

Group 1 - Sanofi has appointed Belén Garijo as the new CEO, replacing Paul Hudson, whose mandate will not be renewed [1][1][1] - Hudson will step down on February 17, while Garijo will officially take over after the shareholder meeting on April 29 [1][1][1] - Olivier Charmeil, a board member, will serve as interim CEO during the transition period [1][1][1] Group 2 - Belén Garijo has 15 years of experience at Sanofi and has held significant positions, including board member at L'Oreal and CEO of Merck KGaA [1][1][1] - The chairman of Sanofi, Frederic Oudea, expressed confidence in Garijo's ability to accelerate strategy execution and lead the company's next growth cycle [1][1][1]